Many medical conditions are well served by proven medicines. Patients living with such diseases depend on these medicines’ reliability, availability, and quality. pharma& ensures that such proven medicines will be available in the future, acquiring the rights to treatments to keep them available worldwide.

for patients living in the U.S.A.

pharma& recognizes that it is important to provide access to medications for patients and may offer financial support to eligible patients in the U.S.A. undergoing treatment with Pegasys® (peginterferon alfa-2a) or Rubraca® (rucaparib).

To enroll for Pegasys coverage assistance, download the pharma& Patient Assistance Program form.

To enroll for Rubraca coverage assistance, please visit the Rubraca website.